How has the COVID-19 pandemic affected patients with primary bladder cancer?

Basit Öğe Kaydı
dc.authoridBayraktar, Arif Bedirhan/0000-0002-2373-5929
dc.authoridYildiz, Ali Kaan/0000-0002-0999-9872
dc.contributor.authorYildiz, Ali K.
dc.contributor.authorOzgur, Berat C.
dc.contributor.authorBayraktar, Arif S.
dc.contributor.authorDemir, Demirhan O.
dc.contributor.authorDoluoglu, Omer G.
dc.date.accessioned2024-09-29T16:07:45Z
dc.date.available2024-09-29T16:07:45Z
dc.date.issued2023
dc.departmentKarabük Üniversitesien_US
dc.description.abstractPurpose. The COVID-19-induced effects of primary bladder cancer (BC) patients have not yet been clarified. The aim of this study was to investigate the effects of the pandemic on the diagnosis, treatment, and follow-up of primary BC patients. Material and methods. A retrospective single-center analysis was made of all patients who underwent diagnostic and surgical procedures due to primary BC between November 2018 and July 2021. A total of 275 patients were identified and allocated to one of the groups: Pre-COVIDBC (BC diagnosed before the COVID-19 pandemic) or COVIDBC (during the pandemic). Results. The BC patients diagnosed during the pandemic were mostly at higher stages (T2) (p = 0.04), the risk of non-muscle invasive BC (NMIBC) was higher (p = 0.02), and recurrence and progression scores were increased (p = 0.001) compared to patients diagnosed before the pandemic. The time to surgery from diagnosis (p = 0.001) and symptom duration (p = 0.04) were significantly prolonged during the pandemic and the rate of follow-up significantly decreased (p = 0.03). Conclusions. The study results highlight the significant increase in muscle invasive BC and the very high risk of NMIBC in patients presenting during the COVID-19 pandemic.en_US
dc.identifier.doi10.24875/CIRU.22000204
dc.identifier.endpage211en_US
dc.identifier.issn0009-7411
dc.identifier.issue2en_US
dc.identifier.pmid37084297en_US
dc.identifier.scopus2-s2.0-85153549451en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage204en_US
dc.identifier.urihttps://doi.org/10.24875/CIRU.22000204
dc.identifier.urihttps://hdl.handle.net/20.500.14619/7143
dc.identifier.volume91en_US
dc.identifier.wosWOS:000976963000008en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherMexican Acad Surgeryen_US
dc.relation.ispartofCirugia Y Cirujanosen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectBladder canceren_US
dc.subjectCOVID-19en_US
dc.subjectPandemicen_US
dc.subjectTumoren_US
dc.subjectTumor stageen_US
dc.subjectGradeen_US
dc.subjectTransurethral resectionen_US
dc.titleHow has the COVID-19 pandemic affected patients with primary bladder cancer?en_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu